This article originally appeared in the "News You Can Use" section of CONTROL SOLUTIONS, Summer 2004 edition, published by Integrated Diabetes Services
Men and women with diabetes (type 1 or type 2) are at greatly increased risk of developing cardiovascular disease. One of the primary reasons is increased production of thromboxane, which causes blood vessels to constrict and platelets within the bloodstream to become extra "sticky." Because it blocks the production of thromboxane, low-dose aspirin therapy has been shown to be an effective method for preventing heart disease and stroke. The American Diabetes Association recommends daily low-dose aspirin (75-162mg) for the following people:
* Those with a personal history of circulatory disease (heart attack, stroke,
t.i.a. (transient ischemic attack), impaired circulation in the hands or feet)
* Those with type 2 diabetes who are over age 40, or who have other factors
for cardiovascular disease (positive family history, high blood pressure, smoking,
elevated cholesterol, protein in urine)
* Those with type 1 diabetes who are over age 40, or with other risk factors
for cardiovascular disease
Aspirin therapy is not recommended for those under age 21, or anyone who suffers
from bleeding problems. For more information, consult your physician.
CONTROL SOLUTIONS is a free newsletter published by Integrated Diabetes Solutions.
For a free subscription, you can call Integrated Diabetes Solutions at (610)642-6055,
or you can e-mail them at (garyscheiner@prodigy.net).